2020-2025 Global Multiplex Assays Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

As the information around signaling pathways and potentially drugable targets expands, there is increasing pressure to quickly probe these pathways. There is a greater need to understand the nature of protein-protein interactions within signaling pathways and to identify biomarkers of metabolic processes. Singleplex detection methods such as ELISA or Western blot assays are not suitable for rapid investigation of complex signaling pathways composed of several members. Multiplex Assays offers the ability to multiplex detection of several proteins from a single biological sample. Multiplex Assays allows for multiplexing of many types of assays thus reducing time, labor, and costs over traditional methods.
This report elaborates the market size, market characteristics, and market growth of the Multiplex Assays industry, and breaks down according to the type, application, and consumption area of Multiplex Assays. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Multiplex Assays in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Multiplex Assays market covered in Chapter 13:
Luminex Corporation
Illumina, Inc.
Merck KGAA
Abcam PLC
Seegene Inc.
Randox Laboratories
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories Inc.
Qiagen N.V.
Becton, Dickinson and Company
Meso Scale Diagnostics, LLC.

In Chapter 6, on the basis of types, the Multiplex Assays market from 2015 to 2025 is primarily split into:
Nucleic Acid-Based Multiplex Assays
Protein-Based Multiplex Assays

In Chapter 7, on the basis of applications, the Multiplex Assays market from 2015 to 2025 covers:
Research & Development
Diseases & Disorders
Companion Diagnostics
Other Applications

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025